Cargando…
Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway
The protective mechanism of paricalcitol remains unclear in renal ischemia-reperfusion (IR) injury. We investigated the renoprotective effects of paricalcitol in IR injury through the prostaglandin E(2) (PGE(2)) receptor EP4. Paricalcitol was injected into IR-exposed HK-2 cells and mice subjected to...
Autores principales: | Hong, Yu Ah, Yang, Keum Jin, Jung, So Young, Park, Ki Cheol, Choi, Hyunsu, Oh, Jeong Min, Lee, Sang Ju, Chang, Yoon Kyung, Park, Cheol Whee, Yang, Chul Woo, Kim, Suk Young, Hwang, Hyeon Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390586/ https://www.ncbi.nlm.nih.gov/pubmed/28465762 http://dx.doi.org/10.1155/2017/5031926 |
Ejemplares similares
-
Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway”
por: Hong, Yu Ah, et al.
Publicado: (2017) -
Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E(2) receptor EP4
por: Hong, Yu Ah, et al.
Publicado: (2017) -
Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation
por: Hong, Yu Ah, et al.
Publicado: (2020) -
Neuroprotective effect of paricalcitol in a rat model of transient global cerebral ischemia
por: Kim, Sung Wook, et al.
Publicado: (2020) -
Laminarin Pretreatment Provides Neuroprotection against Forebrain Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Neuroinflammation in Aged Gerbils
por: Park, Joon Ha, et al.
Publicado: (2020)